{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:36:15Z","timestamp":1791488175466,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012491","name":"Science and Technology Development Center, Ministry of Education","doi-asserted-by":"publisher","award":["3M213BR43428"],"award-info":[{"award-number":["3M213BR43428"]}],"id":[{"id":"10.13039\/501100012491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201306170107"],"award-info":[{"award-number":["201306170107"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["3D511Z933428"],"award-info":[{"award-number":["3D511Z933428"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jdiacomp.2015.06.016","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:58:18Z","timestamp":1436403498000},"page":"1345-1351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Metabolomic biomarkers in diabetic kidney diseases\u2014A systematic review"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1274-5440","authenticated-orcid":false,"given":"Yumin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdiacomp.2015.06.016_bb0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/gm333","article-title":"Genome-wide association studies with metabolomics","volume":"4","author":"Adamski","year":"2012","journal-title":"Genome Medicine"},{"issue":"2","key":"10.1016\/j.jdiacomp.2015.06.016_bb0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1016\/j.jdiacomp.2015.06.016_bb0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1124\/jpet.110.168815","article-title":"Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet","volume":"334","author":"Boini","year":"2010","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"18","key":"10.1016\/j.jdiacomp.2015.06.016_bb0020","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","article-title":"Metabolite profiling identifies pathways associated with metabolic risk in humans","volume":"125","author":"Cheng","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jdiacomp.2015.06.016_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2050-7771-1-17","article-title":"Metabolomic analyses for atherosclerosis, diabetes, and obesity","volume":"1","author":"Du","year":"2013","journal-title":"Biomarker Research"},{"issue":"12","key":"10.1016\/j.jdiacomp.2015.06.016_bb0030","doi-asserted-by":"crossref","first-page":"e15234","DOI":"10.1371\/journal.pone.0015234","article-title":"Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women","volume":"5","author":"Fiehn","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jdiacomp.2015.06.016_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/j.jrn.2006.01.004","article-title":"Relationship between serum carnitine, acylcarnitines, and renal function in patients with chronic renal disease","volume":"16","author":"Fouque","year":"2006","journal-title":"Journal of Renal Nutrition"},{"issue":"16","key":"10.1016\/j.jdiacomp.2015.06.016_bb0040","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990-2010","volume":"370","author":"Gregg","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jdiacomp.2015.06.016_bb0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jdiacomp.2015.06.016_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.aca.2011.01.034","article-title":"Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy","volume":"689","author":"Han","year":"2011","journal-title":"Analytica Chimica Acta"},{"issue":"1","key":"10.1016\/j.jdiacomp.2015.06.016_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3945\/jn.114.196840","article-title":"Nontargeted metabolite profiling discriminates diet-specific biomarkers for consumption of whole grains, fatty fish, and bilberries in a randomized controlled trial","volume":"145","author":"Hanhineva","year":"2015","journal-title":"The Journal of Nutrition"},{"issue":"10","key":"10.1016\/j.jdiacomp.2015.06.016_bb0060","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00216-012-6412-x","article-title":"Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy","volume":"404","author":"Hirayama","year":"2012","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"12","key":"10.1016\/j.jdiacomp.2015.06.016_bb0065","first-page":"3354","article-title":"Metabolic disorder of purine nucleotide in patients with renal disease","volume":"54","author":"Hosoya","year":"1996","journal-title":"Nihon Rinsho"},{"issue":"3","key":"10.1016\/j.jdiacomp.2015.06.016_bb0070","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.ackd.2014.03.008","article-title":"New insights into the use of biomarkers of diabetic nephropathy","volume":"21","author":"Jha","year":"2014","journal-title":"Advances in Chronic Kidney Disease"},{"issue":"4","key":"10.1016\/j.jdiacomp.2015.06.016_bb0075","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.talanta.2008.08.031","article-title":"HPLC-electrospray tandem mass spectrometry for simultaneous quantitation of eight plasma aminothiols: application to studies of diabetic nephropathy","volume":"77","author":"Jiang","year":"2009","journal-title":"Talanta"},{"issue":"10","key":"10.1016\/j.jdiacomp.2015.06.016_bb0080","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.2337\/db11-0425","article-title":"Fatty acids, obesity, and insulin resistance: time for a reevaluation","volume":"60","author":"Karpe","year":"2011","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.jdiacomp.2015.06.016_bb0085","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.metabol.2014.07.001","article-title":"Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes","volume":"63","author":"Klein","year":"2014","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jdiacomp.2015.06.016_bb0090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2337\/dc13-0985","article-title":"Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria","volume":"37","author":"Krolewski","year":"2014","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.jdiacomp.2015.06.016_bb0095","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1373\/clinchem.2013.207993","article-title":"Diabetes subphenotypes and metabolomics: the key to discovering laboratory markers for personalized medicine?","volume":"59","author":"Lehmann","year":"2013","journal-title":"Clinical Chemistry"},{"issue":"1","key":"10.1016\/j.jdiacomp.2015.06.016_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5527\/wjn.v4.i1.57","article-title":"Biomarkers in chronic kidney disease, from kidney function to kidney damage","volume":"4","author":"Lopez-Giacoman","year":"2015","journal-title":"World Journal of Nephrology"},{"issue":"3","key":"10.1016\/j.jdiacomp.2015.06.016_bb0105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/dme.12352","article-title":"Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy","volume":"31","author":"Lowe","year":"2014","journal-title":"Diabetic Medicine"},{"issue":"1","key":"10.1016\/j.jdiacomp.2015.06.016_bb0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11684-013-0248-4","article-title":"Metabolomics in human type 2 diabetes research","volume":"7","author":"Lu","year":"2013","journal-title":"Frontiers of Medicine"},{"issue":"9","key":"10.1016\/j.jdiacomp.2015.06.016_bb0115","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1021\/pr300523x","article-title":"Serum metabolic signatures of fulminant type 1 diabetes","volume":"11","author":"Lu","year":"2012","journal-title":"Journal of Proteome Research"},{"issue":"16-17","key":"10.1016\/j.jdiacomp.2015.06.016_bb0120","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.clinbiochem.2008.06.018","article-title":"QUADOMICS: an adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of '-omics'-based technologies","volume":"41","author":"Lumbreras","year":"2008","journal-title":"Clinical Biochemistry"},{"issue":"3","key":"10.1016\/j.jdiacomp.2015.06.016_bb0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11306-011-0343-y","article-title":"Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study)","volume":"8","author":"Makinen","year":"2012","journal-title":"Metabolomics"},{"issue":"3","key":"10.1016\/j.jdiacomp.2015.06.016_bb0130","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1021\/pr201036j","article-title":"Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study)","volume":"11","author":"Makinen","year":"2012","journal-title":"Journal of Proteome Research"},{"issue":"3","key":"10.1016\/j.jdiacomp.2015.06.016_bb0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.ackd.2014.03.010","article-title":"Genetic and epigenetic risk factors for diabetic kidney disease","volume":"21","author":"McKnight","year":"2014","journal-title":"Advances in Chronic Kidney Disease"},{"key":"10.1016\/j.jdiacomp.2015.06.016_bb0140","first-page":"127","article-title":"Podocyte pathology and nephropathy - sphingolipids in glomerular diseases","volume":"5","author":"Merscher","year":"2014","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"Suppl. 2","key":"10.1016\/j.jdiacomp.2015.06.016_bb0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diab.32.2.S64","article-title":"The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy","volume":"32","author":"Mogensen","year":"1983","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jdiacomp.2015.06.016_bb0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10157-013-0874-9","article-title":"Genetic associations in diabetic nephropathy","volume":"18","author":"Mooyaart","year":"2014","journal-title":"Clinical and Experimental Nephrology"},{"issue":"2","key":"10.1016\/j.jdiacomp.2015.06.016_bb0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00125-011-2339-6","article-title":"A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus","volume":"55","author":"Ng","year":"2012","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.jdiacomp.2015.06.016_bb0160","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/ki.2013.497","article-title":"Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study","volume":"85","author":"Niewczas","year":"2014","journal-title":"Kidney International"},{"issue":"8","key":"10.1016\/j.jdiacomp.2015.06.016_bb0165","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng.2352","article-title":"Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations","volume":"44","author":"Okada","year":"2012","journal-title":"Nature Genetics"},{"issue":"1-2","key":"10.1016\/j.jdiacomp.2015.06.016_bb0170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jchromb.2008.05.027","article-title":"Simultaneous determination and quantification of seven major phospholipid classes in human blood using normal-phase liquid chromatography coupled with electrospray mass spectrometry and the application in diabetes nephropathy","volume":"869","author":"Pang","year":"2008","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"7","key":"10.1016\/j.jdiacomp.2015.06.016_bb0175","doi-asserted-by":"crossref","first-page":"e11419","DOI":"10.1371\/journal.pone.0011419","article-title":"Methodological deficits in diagnostic research using '-omics' technologies: evaluation of the QUADOMICS tool and quality of recently published studies","volume":"5","author":"Parker","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jdiacomp.2015.06.016_bb0180","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000049069","article-title":"Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure","volume":"90","author":"Pawlak","year":"2002","journal-title":"Nephron"},{"issue":"9","key":"10.1016\/j.jdiacomp.2015.06.016_bb0185","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/dme.12447","article-title":"Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus","volume":"31","author":"Pena","year":"2014","journal-title":"Diabetic Medicine"},{"issue":"1","key":"10.1016\/j.jdiacomp.2015.06.016_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ki.2009.399","article-title":"In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria","volume":"77","author":"Perkins","year":"2010","journal-title":"Kidney International"},{"issue":"5","key":"10.1016\/j.jdiacomp.2015.06.016_bb0195","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/clpt.2013.120","article-title":"Metabolomics in drug discovery and development","volume":"94","author":"Robertson","year":"2013","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.jdiacomp.2015.06.016_bb0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physiolgenomics.00194.2006","article-title":"A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human","volume":"29","author":"Salek","year":"2007","journal-title":"Physiological Genomics"},{"issue":"3","key":"10.1016\/j.jdiacomp.2015.06.016_bb0205","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2337\/db14-0509","article-title":"Metabolomics and Diabetes: Analytical and Computational Approaches","volume":"64","author":"Sas","year":"2015","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.jdiacomp.2015.06.016_bb0210","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1681\/ASN.2013020126","article-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","volume":"24","author":"Sharma","year":"2013","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl. 2","key":"10.1016\/j.jdiacomp.2015.06.016_bb0215","first-page":"s78","article-title":"Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint","volume":"10","author":"Sirolli","year":"2012","journal-title":"Blood Transfusion"},{"issue":"3","key":"10.1016\/j.jdiacomp.2015.06.016_bb0220","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/JOE-14-0024","article-title":"Metabolic profiling in diabetes","volume":"221","author":"Suhre","year":"2014","journal-title":"The Journal of Endocrinology"},{"issue":"11","key":"10.1016\/j.jdiacomp.2015.06.016_bb0225","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrg3314","article-title":"Genetic variation in metabolic phenotypes: study designs and applications","volume":"13","author":"Suhre","year":"2012","journal-title":"Nature Reviews. Genetics"},{"issue":"5","key":"10.1016\/j.jdiacomp.2015.06.016_bb0230","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1087057111402200","article-title":"Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing","volume":"16","author":"Suhre","year":"2011","journal-title":"Journal of Biomolecular Screening"},{"issue":"9","key":"10.1016\/j.jdiacomp.2015.06.016_bb0235","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/ajcn\/31.9.1581","article-title":"Metabolism of urea cycle intermediates in chronic renal failure","volume":"31","author":"Swendseid","year":"1978","journal-title":"The American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1016\/j.jdiacomp.2015.06.016_bb0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11306-011-0291-6","article-title":"Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)","volume":"8","author":"van der Kloet","year":"2012","journal-title":"Metabolomics"},{"issue":"4","key":"10.1016\/j.jdiacomp.2015.06.016_bb0250","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nature Medicine"},{"issue":"9","key":"10.1016\/j.jdiacomp.2015.06.016_bb0245","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2217\/fon.10.107","article-title":"Metabolomics and detection of colorectal cancer in humans: a systematic review","volume":"6","author":"Wang","year":"2010","journal-title":"Future Oncology"},{"issue":"2","key":"10.1016\/j.jdiacomp.2015.06.016_bb0255","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1123\/ijsnem.2013-0048","article-title":"Serum metabolites related to cardiorespiratory fitness, physical activity energy expenditure, sedentary time and vigorous activity","volume":"24","author":"Wientzek","year":"2014","journal-title":"International Journal of Sport Nutrition and Exercise Metabolism"},{"issue":"12","key":"10.1016\/j.jdiacomp.2015.06.016_bb0260","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.clinbiochem.2010.05.013","article-title":"Correlations of creatine and six related pyrimidine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients","volume":"43","author":"Xia","year":"2010","journal-title":"Clinical Biochemistry"},{"issue":"20-21","key":"10.1016\/j.jdiacomp.2015.06.016_bb0265","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jchromb.2009.05.047","article-title":"Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy","volume":"877","author":"Xia","year":"2009","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"11","key":"10.1016\/j.jdiacomp.2015.06.016_bb0275","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1021\/pr900524z","article-title":"Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses","volume":"8","author":"Zhang","year":"2009","journal-title":"Journal of Proteome Research"},{"issue":"1","key":"10.1016\/j.jdiacomp.2015.06.016_bb0270","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.aca.2009.02.027","article-title":"Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system","volume":"650","author":"Zhang","year":"2009","journal-title":"Analytica Chimica Acta"},{"issue":"12","key":"10.1016\/j.jdiacomp.2015.06.016_bb0280","doi-asserted-by":"crossref","first-page":"e115467","DOI":"10.1371\/journal.pone.0115467","article-title":"A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF\/HDMS","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jdiacomp.2015.06.016_bb0285","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.talanta.2011.05.036","article-title":"Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy","volume":"85","author":"Zhu","year":"2011","journal-title":"Talanta"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872715002755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872715002755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T03:21:29Z","timestamp":1657336889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872715002755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1056872715002755"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.06.016","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic biomarkers in diabetic kidney diseases\u2014A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}